Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance of common stock (in shares) at Dec. 31, 2021   72,027,743      
Beginning balance of stockholders' equity at Dec. 31, 2021 $ 256,208 $ 7 $ 401,702 $ (3,463) $ (142,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (2,496)     (2,496)  
Stock-based compensation expense 4,551   4,551    
Common stock issued pursuant to acquisition (in shares)   4,212,246      
Common stock issued pursuant to acquisition 23,295 $ 1 23,294    
Net loss (22,362)       (22,362)
Ending balance of common stock (in shares) at Jun. 30, 2022   76,239,989      
Ending balance of stockholders' equity at Jun. 30, 2022 259,196 $ 8 429,547 (5,959) (164,400)
Beginning balance of common stock (in shares) at Mar. 31, 2022   76,239,989      
Beginning balance of stockholders' equity at Mar. 31, 2022 269,858 $ 8 427,046 (3,586) (153,610)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment (2,373)     (2,373)  
Stock-based compensation expense 2,501   2,501    
Net loss (10,790)       (10,790)
Ending balance of common stock (in shares) at Jun. 30, 2022   76,239,989      
Ending balance of stockholders' equity at Jun. 30, 2022 $ 259,196 $ 8 429,547 (5,959) (164,400)
Beginning balance of common stock (in shares) at Dec. 31, 2022 76,292,241 76,292,241      
Beginning balance of stockholders' equity at Dec. 31, 2022 $ 180,672 $ 8 435,292 (6,390) (248,238)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment 258     258  
Stock-based compensation expense 5,575   5,575    
Shares withheld related to net share settlement (in shares)   (134,713)      
Shares withheld related to net share settlement (185)   (185)    
Vesting of restricted stock units (in shares)   395,067      
Common stock issued pursuant to acquisition (in shares)   10,000,000      
Common stock issued pursuant to acquisition 14,700 $ 1 14,699    
Net loss $ (37,989)       (37,989)
Ending balance of common stock (in shares) at Jun. 30, 2023 86,552,595 86,552,595      
Ending balance of stockholders' equity at Jun. 30, 2023 $ 163,031 $ 9 455,381 (6,132) (286,227)
Beginning balance of common stock (in shares) at Mar. 31, 2023   76,552,595      
Beginning balance of stockholders' equity at Mar. 31, 2023 164,695 $ 8 437,677 (6,262) (266,728)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustment 130     130  
Stock-based compensation expense 3,005   3,005    
Common stock issued pursuant to acquisition (in shares)   10,000,000      
Common stock issued pursuant to acquisition 14,700 $ 1 14,699    
Net loss $ (19,499)       (19,499)
Ending balance of common stock (in shares) at Jun. 30, 2023 86,552,595 86,552,595      
Ending balance of stockholders' equity at Jun. 30, 2023 $ 163,031 $ 9 $ 455,381 $ (6,132) $ (286,227)